Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2013

View Archived Issues

Leica Biosystems and Synthon Biopharmaceuticals enter partnership

Gedeon Richter divulges novel H3 receptor ligands

Pfizer prepares new BRD4 inhibitors

The novel mechanistic properties of AF-710B result in excellent cognitive enhancement in vivo

Tyrosine-protein kinase BTK as promising biomarker for lymphomas

Safety of ZN-2007 evaluated in rats and monkeys

MiStent demonstrates significant neointimal suppression in human coronary lesions

Bexarotene restores memory deficit in transgenic models of Alzheimer's disease

Sinovac's EV71 vaccine shows efficacy against HFMD in phase III study

Nanosphere gains clearance in E.U. for Gram-Negative Blood Culture test

The role of CD28 in controlling Treg function and survival

Novel Chinese yam-derived protein patented for menopause and osteoporosis

A novel selective NMDA receptor antagonist shows promising results in vivo

ThromboGenics discloses potential new eye disorder treatments

Genfit discovers novel ligands for the treatment of autoimmune diseases

FDA sets PDUFA date for QRxPharma's resubmitted MoxDuo NDA

Oxford Gene Technology obtains license to prostate cancer biomarker

PRASFIT-Elective study results announced by Daiichi Sankyo

G-202 obtains FDA orphan drug designation

Novel cancer peptide vaccines prepared in Japan

ARC-520 reduces circulating HBV DNA in chimpanzee with chronic hepatitis B

Isofol Medical completes first part of preclinical safety program for Modufolin

Ligand signs global license agreement with Spectrum for Captisol-enabled melphalan

Vanda withdraws MAA for schizophrenia treatment candidate

FDA reviewing possible safety risk associated with incretin mimetic drugs for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.